1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Cardiovascular disease risk in early rheumatoid arthritis : the impact of cartilage oligomeric matrix protein (COMP) and disease activity
(
- Contribution to journal › Article
- 2013
-
Mark
COMP-C3b Complexes in Rheumatoid Arthritis with Severe Extraarticular Manifestations.
(
- Contribution to journal › Article
-
Mark
Reumatologisk forskning i Lund/Malmö
(
- Contribution to specialist publication or newspaper › Newspaper article
- 2011
-
Mark
Delays in assessment of patients with rheumatoid arthritis: variations across Europe
(
- Contribution to journal › Article
-
Mark
Increased cartilage turnover and circulating autoantibodies in different subsets before the clinical onset of rheumatoid arthritis.
(
- Contribution to journal › Article
- 2008
-
Mark
Increased serum levels of cartilage oligomeric matrix protein precede the clinical onset of rheumatoid arthritis despite lower levels among smokers
2008) 72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals In Arthritis and Rheumatism 58(9). p.289-290(
- Contribution to journal › Published meeting abstract
- 2007
-
Mark
Treatment with TNF-blockers and mortality risk in patients with rheumatoid arthritis.
(
- Contribution to journal › Article
- 2006
-
Mark
Allvarlig lungsjukdom vid RA och TNF-blockering--finns det ett samband?
(
- Contribution to journal › Article
- 2005
-
Mark
Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas
(
- Contribution to journal › Article